ELVN ENLIVEN THERAPEUTICS INC
2026Q1 · CUSIP 29337E102 · Sector: Healthcare & Biotech
Lit · Institutions accelerating in
Holders
163
Δ holders QoQ
+35
Breadth percentile
Top 8%
Whale holders
80
Δ whales
+14
Inst. holding value
$2.3B
New positions
57
Closed positions
22
Price momentum (1Q)
+51.7%
Put / Call
6/5
Breadth history (34 quarters)
Past Lit Events & Aftermath 3 lit events
| Period | Percentile | Next-1Q return | Next-2Q return |
|---|---|---|---|
| 2026Q1 | Top 8% | — | — |
| 2024Q2 | Top 13% | +5.1% | -7.6% |
| 2023Q2 | Top 12% | -28.3% | +12.8% |
Options Sentiment
Put holders
6
QoQ: +4
Call holders
5
QoQ: +5
See methodology →
Fundamentals
PE (TTM)
—
EPS (TTM)
$-1.64
EPS YoY
—
Revenue (TTM)
—
Revenue YoY
—
Quarterly Revenue & EPS (4Y)
Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable
As of 2026-03-31 · SEC filings (XBRL)